Pharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a key senator charged Wednesday, in the latest effort by Democrats to pressure drug companies on the ...

Both inhalers provide the advantage of once-daily dosing, a key difference from their comparators, which typically require multiple inhalers used twice daily.

After a year of controversy and complaints, U.S. Sen. Elizabeth Warren (D-Mass.) is asking a federal watchdog to investigate GSK for replacing a popular asthma inhaler with a so-called authorized ...

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

The FDA approved GSK's Blujepa for uncomplicated UTIs in female adults and pediatric patients, with phase 3 trials showing strong efficacy vs. nitrofurantoin.

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

Patients were not sufficiently worn about “deviant” sexual behavior and other extreme side effects caused by common medications prescribed for Parkinson’s and Restless Leg Syndrome (RLS), a ...

THE second phase of GSK Malaysia’s #GiveBack campaign has been launched to encourage proper disposal of medical waste. Under the campaign, designated collection points are provided to people ...

The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and value of GSK Plc's (NYSE:GSK) chronic obstructive pulmonary disease (COPD) ...